Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2022

Sep 16, 2022

34395_dirs_2022-09-16_2d270106-0394-44e4-a003-b6a520fb56ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-23-05:00

Reporting Person: Butera Salvatore Thomas (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 135000 Direct
Common Stock 37000 Direct

Footnotes

F1: On November 18, 2021, June 17, 2022, August 23, 2022 and August 24, 2022, the reporting person filed certain Form 4's reporting the market purchase of an aggregate of 30,000 shares of common stock. The reporting person inadvertently omitted to disclose that these shares were purchased jointly with his spouse.

F2: These shares of common stock are jointly owned by the reporting person and his spouse.